In the last check Thursday, Senti Biosciences Inc. (SNTI) gained 49.81% at $7.91 after announcing it would display its posters at an event. SNTI fluctuated between $3.55 and $5.29 during the previous trading session.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
What will the display locations be for SNTI posters?
Senti Bio (SNTI) announced two poster presentations at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), which will be held in Boston, MA, November 10-12, 2022. Posters from SNTI will be displayed at Poster Hall C on November 10, 2022, from 9:00 am to 9:00 pm EDT:
- “Multi-Arming and Regulator Dial Gene Circuits Tackle Key Challenges in Solid Tumors”
- “SENTI-401, an Allogeneic Logic-Gated and Multi-Armed CAR-NK Cell Therapy for the Treatment of CEA-Expressing Solid Tumors with Enhanced Selectivity and Efficacy”
Major event participation
Also this week, Senti Bio participated in an important event. The Chardan 6th Annual Genetic Medicines Conference on Monday, October 3, 2022, at 1:30 PM ET, featured Tim Lu, Deb Knobelman, and Kanya Rajangam as co-founders and CEOs of SNTI, as well as a Fireside Chat by SNTI, CEO Tim Lu, CFO Deb Knobelman, and CMDO Kanya Rajangam. On Tuesday, October 4, 2022, at 9:30 AM ET, Tim Lu attended a panel discussion on Gene Regulation.
Under the Investors tab of the Senti Bio website, live webcasts of the Fireside Chat were available under the Events & Presentations section. They will be available for 120 days following the presentation.
Equity initiatives at SNTI:
A global investment bank, Chardan has launched the Chardan Equity Facility (ChEF), an innovative financing solution tailored to meet the individual needs of its clients. As a result of the ChEF, companies can raise equity on a periodic basis after going public, rather than in the traditional context of an underwritten follow-on offering. ChEFs have been announced by Senti Bio (SNTI), which has agreed to enter into a $50 million ChEF, and Dragonfly Energy (CNTQ), which has agreed to enter into a $150 million ChEF.